PSILOCYBIN STUDIES TURN A NEW LEAF
Chemical & Engineering News – July 17, 2006
Source: OpenAlex
Summary
A significant shift is transforming the scientific approach to psilocybin. Since 2006, the field has aimed to establish a sound scientific footing for psychedelics research. This new turn in drug studies emphasizes rigorous methodology, exploring the complex chemistry of this potent hallucinogen. The goal is to move beyond anecdotal understanding, ensuring robust data collection for psilocybin and related compounds. This commitment to scientific integrity promises to deepen our understanding of these substances.
Abstract
RETURN TO ISSUEPREVNewsNEXTPSILOCYBIN STUDIES TURN A NEW LEAFScientists aim to set psychedelics research on a sound scientific footingIVAN AMATOCite this: Chem. Eng. News 2006, 84, 29, 10Publication Date (Print):July 17, 2006Publication History Published online14 November 2010Published inissue 17 July 2006https://pubs.acs.org/doi/10.1021/cen-v084n029.p010ahttps://doi.org/10.1021/cen-v084n029.p010anewsACS PublicationsCopyright © 2006 AMERICAN CHEMICAL SOCIETYArticle Views29Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access options SUBJECTS:Central nervous system,Pharmaceuticals Get e-Alerts